Cargando…

Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy

BACKGROUND: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesopha...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Zhang, Ye, Li, Zhengjiang, Liu, Shaoyan, Li, Huizheng, Xu, Zhengang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658928/
https://www.ncbi.nlm.nih.gov/pubmed/29073917
http://dx.doi.org/10.1186/s13014-017-0900-2
_version_ 1783274077261135872
author Liu, Jie
Zhang, Ye
Li, Zhengjiang
Liu, Shaoyan
Li, Huizheng
Xu, Zhengang
author_facet Liu, Jie
Zhang, Ye
Li, Zhengjiang
Liu, Shaoyan
Li, Huizheng
Xu, Zhengang
author_sort Liu, Jie
collection PubMed
description BACKGROUND: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. METHODS: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. RESULTS: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery ≤6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. CONCLUSIONS: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy.
format Online
Article
Text
id pubmed-5658928
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56589282017-10-31 Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy Liu, Jie Zhang, Ye Li, Zhengjiang Liu, Shaoyan Li, Huizheng Xu, Zhengang Radiat Oncol Research BACKGROUND: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. METHODS: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. RESULTS: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery ≤6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. CONCLUSIONS: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy. BioMed Central 2017-10-26 /pmc/articles/PMC5658928/ /pubmed/29073917 http://dx.doi.org/10.1186/s13014-017-0900-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Jie
Zhang, Ye
Li, Zhengjiang
Liu, Shaoyan
Li, Huizheng
Xu, Zhengang
Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
title Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
title_full Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
title_fullStr Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
title_full_unstemmed Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
title_short Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
title_sort benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658928/
https://www.ncbi.nlm.nih.gov/pubmed/29073917
http://dx.doi.org/10.1186/s13014-017-0900-2
work_keys_str_mv AT liujie benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy
AT zhangye benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy
AT lizhengjiang benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy
AT liushaoyan benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy
AT lihuizheng benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy
AT xuzhengang benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy